August 8, 2023
Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress
August 3, 2023
Revolution Medicines to Report Financial Results for Second Quarter 2023 After Market Close on August 8, 2023
August 1, 2023
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital
May 8, 2023
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
May 1, 2023
Revolution Medicines to Report Financial Results for First Quarter 2023 After Market Close on May 8, 2023
April 6, 2023
Revolution Medicines to Present Preclinical Data at the Upcoming American Association for Cancer Research Annual Meeting 2023
Displaying 11 - 20 of 121